Skip to main content

Risk for Severe Maternal Morbidity Elevated for Pregnancy Surrogates

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 24, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 23, 2024 -- The risk for severe maternal morbidity (SMM) and adverse pregnancy outcomes is increased for gestational carriers, or pregnancy surrogates, compared with women conceiving naturally or via in vitro fertilization (IVF), according to a study published online Sept. 24 in the Annals of Internal Medicine.

Maria P. Velez, M.D., Ph.D., from Queen's University Kingston in Ontario, Canada, and colleagues conducted a population-based cohort study to examine the risk for SMM and severe neonatal morbidity (SNM) in gestational carriers.

Of the eligible singleton births, 846,124, 16,087, and 806 (97.6, 1.8, and 0.1 percent, respectively), were via unassisted conception, IVF, and gestational carriage, respectively. The researchers found that the risks for SMM were 2.3, 4.3, and 7.8 percent for unassisted conception, IVF, and gestational carriage, respectively. The weighted relative risks were 3.30 and 1.86, respectively, comparing gestational carriage with unassisted conception and IVF. For SNM, the respective risks were 5.9, 8.9, and 6.6 percent; the weighted relative risks were not significantly increased for gestational carriage versus unassisted conception or IVF. Comparing gestational carriers with either comparison group, hypertensive disorder, postpartum hemorrhage, and preterm birth at less than 37 weeks were also significantly higher.

"Given the increasing use of gestational carriers, and the potentially higher risk for SMM and other adverse pregnancy outcomes, a judicious selection of these carriers may be warranted -- something recommended within clinical practice guidelines," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use

WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...

Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk

TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...

USPSTF Continues to Recommend Syphilis Screening Early in Pregnancy

TUESDAY, May 13, 2025 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening for syphilis during pregnancy. This recommendation forms the basis of a final...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.